Professional Documents
Culture Documents
Conference 2016
Gary Guthart
President and CEO
Agenda
2015 Review
da Vinci Value
Opportunities/Catalysts
2016 Priorities
2015 Commentary
2015 Objectives
Expanding da Vinci in general
surgery, particularly colorectal
surgery and hernia repair
Filling out our product line for
da Vinci Xi and launching in key
markets globally
Developing our organizational
capabilities and markets in
Europe and Asia
Advancing our technologies to
improve surgery
Lowering our direct product costs
Areas of Strength
General surgery growth
International procedure
growth
da Vinci Xi product line
and feature set
Growing acceptance of
robotic -assisted surgery
Extensive, established
da Vinci ecosystem
Challenges
Structural barriers in
some markets
Single-Site procedures
800,000
2015:
14% Growth
700,000
600,000
500,000
400,000
300,000
200,000
100,000
0
2010
2011
Urology
Company estimates
2012
Gynecology
2013
2014
General Surgery
2015
Other
2016
US Procedure Trend
+11%
500,000
400,000
300,000
200,000
100,000
0
2010
Urology
Company estimates
2011
2012
Gynecology
2013
General Surgery
2014
2015
Other
+26%
140,000
120,000
100,000
80,000
60,000
40,000
20,000
0
2010
2011
Europe
Company estimates
2012
2013
Asia
Rest of World
2014
2015
2015 +14%
140
120
100
80
60
40
20
0
Q1
Q2
Q3
Q4
Q1
2014
U.S.
Q2
Q3
2015
Europe
Asia
Rest-of-World
Q4
2015 +14%
140
120
100
80
60
40
20
0
Q1
Q2
Q3
Q4
Q1
2014
Q2
Q3
2015
Xi
Si
S / Sie
Q4
Total Revenue*
$2,500
2015
70%
Recurring
$2,000
$1,500
$1,000
$500
$0
2010
2011
Systems
2012
Service
2013
2014
Inst & Accy
2015
da Vinci Si-e
$0.6M
Single-Site
$700
Dual Console Xi
Firefly
$2.5M Table Motion
Endowrist
Vessel Sealer
$3,200 Stapler
2015: $138K
da Vinci Si-e
$100K
Dual Console Xi
$170K
DA VINCI VALUE
Readmissions
Surgical site infections (SSI)
da Vinci Ecosystem
Family of da Vinci Systems
3D HD Imaging,
Fluorescent Imaging
Integrated Energy,
Stapling, Vessel Sealing
Analytics and
Efficiency Programs
Other MIS
Open
Other MIS
Open
Other MIS
Open
Ventral
Hernia
Thoracic
ISI Investments
Advanced imaging
Advanced instrumentation and computerenhanced precision at tissue
Less invasive access
Training technologies
Next generation robotic technologies
International organization
Continued clinical and economic validation
da Vinci Sp
2016 PRIORITIES
2016 Priorities
Expand da Vinci in thoracic and general surgery,
particularly colorectal surgery and hernia repair
Advance key technologies extend our product
leadership position
Drive international performance and strengthen
our organization
Maximize total-cost-to-treat value for customers